Mohit Bansal Analyst Performance

Mohit Bansal is a stock analyst at Wells Fargo & Company in the medical sector, covering 23 publicly traded companies. Over the past year, Mohit Bansal has issued 25 stock ratings, including buy and hold recommendations. While full access to Mohit Bansal's proprietary MarketBeat Analyst Ranking is reserved for MarketBeat All Access subscribers, the rating is updated daily to reflect the most recent analyst activity. This profile highlights Mohit Bansal's coverage history, rating activity, and performance tendencies — helping individual investors make more informed trading decisions.

Analyst Rankings, Coverage, and Performance Statistics

Analyst Ranking

Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating MarketBeat

Average Return

00.00% 12-Month ROI

Success Rate

00.00% Profitable Ratings

Total Ratings

44 Last 10 Years

Buy Recommendations

64.29% 27 Buy Ratings

Companies Covered

23 Unique Companies

Ratings Distribution

Rating	Percentage	Count
Strong Buy	0.0%	0 ratings
Buy	64.3%	27 ratings
Hold	35.7%	15 ratings
Sell	0.0%	0 ratings

Out of 42 total stock ratings issued by Mohit Bansal at Wells Fargo & Company, the majority (64.3%) have been Buy recommendations, followed by 35.7% Hold.

Best & Worst Calls

• Best Call

  0000.0%

  AVXS

  Jun 2017

  Subscribe to MarketBeat All Access to get analyst recommendation ROI.
• Worst Call

  000.0%

  CHRS

  Nov 2016

  Subscribe to MarketBeat All Access to get analyst recommendation ROI.

Exchange Coverage

Exchange	Percentage	Count
NASDAQ	78.3% of companies on NASDAQ	18 companies
NYSE	21.7% of companies on NYSE	5 companies

Mohit Bansal, an analyst at Wells Fargo & Company, currently covers 23 companies listed on NASDAQ and NYSE, with the majority traded on NASDAQ.

Coverage Focus

Sector Icon	Sector	Percentage
	Medical 23 companies	100.0%

Mohit Bansal of Wells Fargo & Company specializes in stock coverage within the Medical sector.

Coverage Industries

Industry	Percentage
MED - BIOMED/GENE 15 companies	65.2%
LARGE CAP PHARMA 3 companies	13.0%
PHARMACEUTICAL PREPARATIONS 3 companies	13.0%
MED - DRUGS 1 company	4.3%
BIOLOGICAL PRODUCTS, EXCEPT DIAGNOSTIC 1 company	4.3%

Mohit Bansal's Ratings History at Wells Fargo & Company

Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year 2 Years 3 Years 4 Years 5 Years All Time Timeframe

Start Date

End Date

All Ratings Strong Buy Buy Hold Sell Rating

Recommendation ROI is the percentage between the price on the Report Date to the price 12 months after the report date.
Available with a MarketBeat All Access Subscription

12-Month ROIUpgrade to All Access to use the All ROI Filter

Export to Excel

Company	Report Date	Action	Report Date Price	12-Month Price Target	Rating	12-Month Price & ROI	Details
ABBV AbbVie	9/12/2025	Boost Price Target	$220.09	$260.00	Overweight	$0.00 00.00% ROI
MIST Milestone Pharmaceuticals	9/11/2025	Initiated Coverage	$1.71	$4.00	Overweight	$0.00 00.00% ROI
TVTX Travere Therapeutics	9/11/2025	Boost Price Target	$27.31	$35.00	Overweight	$0.00 00.00% ROI
MLYS Mineralys Therapeutics	9/11/2025	Boost Price Target	$38.56	$50.00	Overweight	$0.00 00.00% ROI
VRTX Vertex Pharmaceuticals	8/6/2025	Upgrade	$374.98	$460.00	Overweight	$0.00 00.00% ROI
BNTX BioNTech	8/5/2025	Set Price Target	$110.04	$150.00	Overweight	$0.00 00.00% ROI
REGN Regeneron Pharmaceuticals	8/1/2025	Downgrade	$545.46	$580.00	Equal Weight	$0.00 00.00% ROI
MRK Merck & Co., Inc.	7/30/2025	Lower Price Target	$83.21	$90.00	Equal Weight	$0.00 00.00% ROI
REGN Regeneron Pharmaceuticals	5/30/2025	Downgrade	$605.39	$580.00	Equal Weight	$0.00 00.00% ROI
XENE Xenon Pharmaceuticals	5/13/2025	Lower Price Target	$29.95	$47.00	Overweight	$0.00 00.00% ROI
Get the Latest News and Ratings for Your Stocks Enter your email address below to receive the latest headlines and analysts' recommendations for your stocks with our free daily email newsletter.
HALO Halozyme Therapeutics	5/7/2025	Boost Price Target	$68.49	$65.00	Equal Weight	$0.00 00.00% ROI
REGN Regeneron Pharmaceuticals	4/30/2025	Lower Price Target	$586.51	$700.00	Overweight	$0.00 00.00% ROI
IRWD Ironwood Pharmaceuticals	4/15/2025	Reiterated Rating	$0.65	$1.00	Equal Weight	$0.00 00.00% ROI
LLY Eli Lilly and Company	3/5/2025	Boost Price Target	$917.63	$1,100.00	Overweight	$0.00 00.00% ROI
ABBV AbbVie	3/5/2025	Boost Price Target	$208.49	$240.00	Overweight	$0.00 00.00% ROI
JAZZ Jazz Pharmaceuticals	2/13/2025	Upgrade	$135.44	$170.00	Overweight	$0.00 00.00% ROI
BIIB Biogen	2/13/2025	Lower Price Target	$134.10	$140.00	Equal Weight	$0.00 00.00% ROI
BIIB Biogen	2/12/2025	Set Price Target	$140.64	$165.00		$0.00 00.00% ROI
BMY Bristol Myers Squibb	2/7/2025	Boost Price Target	$57.21	$62.00	Equal Weight	$0.00 00.00% ROI
ABBV AbbVie	2/3/2025	Boost Price Target	$188.80	$210.00	Overweight	$0.00 00.00% ROI
VRTX Vertex Pharmaceuticals	1/30/2025	Downgrade	$441.52	$460.00	Equal Weight	$0.00 00.00% ROI
LLY Eli Lilly and Company	1/28/2025	Lower Price Target	$808.16	$970.00	Overweight	$0.00 00.00% ROI
VRTX Vertex Pharmaceuticals	1/10/2025	Lower Price Target	$412.11	$460.00	Overweight	$0.00 00.00% ROI
REGN Regeneron Pharmaceuticals	1/10/2025	Lower Price Target	$733.59	$900.00	Overweight	$0.00 00.00% ROI
BIIB Biogen	1/10/2025	Lower Price Target	$150.75	$165.00	Equal Weight	$0.00 00.00% ROI

Stock Forecasts and Research Tools

Sign in to your free account to enjoy these benefits

• In-depth profiles and analysis for 20,000 public companies.
• Real-time analyst ratings, insider transactions, earnings data, and more.
• Our daily ratings and market update email newsletter.

Sign in to your free account to enjoy all that MarketBeat has to offer.

• Sign In
• Create Account

Your Email Address:

Email Address Required

Your Password:

Password Required

Log In

---

or

Sign in with Facebook Sign in with Google

Forgot your password?

Your Email Address:

Please enter your email address.

Please enter a valid email address

Choose a Password:

Please enter your password.

Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character.

Create My Account (Free)

---

or

Sign in with Facebook Sign in with Google

By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.